×
Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database

Frame
Patients

0 +

Patients
Active Studies

0 +

Active Studies
Cancer Types

0

Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

Recently Added Clinical Trials

  • Drug Screening Using Novel IMD in ACC and Salivary Cancers

    NCT Number : NCT05553782

  • Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer

    NCT Number : NCT05553522

  • HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT Number : NCT05553639

  • Tracer-Guided Surgery for Recurrent Prostate Cancer

    NCT Number : NCT05555017

  • A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain Tumors

    NCT Number : NCT05554159

  • Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial

    NCT Number : NCT05554354

  • Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

    NCT Number : NCT05552729

  • Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

    NCT Number : NCT05554328

  • Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer

    NCT Number : NCT05552001

  • Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

    NCT Number : NCT05554341

  • Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

    NCT Number : NCT05554367

  • Study of Chemotherapy Plus Ipatasertib in Participants With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial

    NCT Number : NCT05554380

  • Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

    NCT Number : NCT05554302

  • A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm

    NCT Number : NCT05555342

  • Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

    NCT Number : NCT05555199

  • PET-MRI in Paediatric Brain Tumours

    NCT Number : NCT05553899

  • Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer

    NCT Number : NCT05554276

  • The Genetic Information and Family Testing (GIFT) Study

    NCT Number : NCT05552664

  • A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

    NCT Number : NCT05551936

  • A Study of ASKG315 in Patients With Advanced Solid Tumors.

    NCT Number : NCT05554666

  • PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung

    NCT Number : NCT05553834

  • Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2

    NCT Number : NCT05554432

  • Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

    NCT Number : NCT05554406

  • Drainless Robot-assisted Minimally Invasive Esophagectomy

    NCT Number : NCT05553795

  • Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

    NCT Number : NCT05554419

  • Precision Optical Guidance for Oral Biopsy

    NCT Number : NCT05554133

  • StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

    NCT Number : NCT05553392

  • Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

    NCT Number : NCT05554393

  • Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

    NCT Number : NCT05551767

  • Anticipated Personalization of the Management in Day Hospital Unit Based on a Collection of the PROs Via a Digital Tool

    NCT Number : NCT05552066

  • Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer

    NCT Number : NCT05553990

  • Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study

    NCT Number : NCT05554003

  • Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

    NCT Number : NCT02918474

  • Circulating Tumor Cells (CTC) in Lung Cancer

    NCT Number : NCT02630615

  • Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

    NCT Number : NCT05553873

  • Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

    NCT Number : NCT03407469

  • Phase 1/2a Open-label Trial of BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors

    NCT Number : NCT05555251

  • Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers

    NCT Number : NCT03888651

  • Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

    NCT Number : NCT03583086

  • Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

    NCT Number : NCT02713269

  • H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

    NCT Number : NCT05552781

  • Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

    NCT Number : NCT03990532

  • 18F-Fluciclovine PET-MRI in High-grade Glioma

    NCT Number : NCT05553041

  • EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors

    NCT Number : NCT05554744

  • To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

    NCT Number : NCT05555212

  • Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

    NCT Number : NCT05552846

  • Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

    NCT Number : NCT05553080

  • TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

    NCT Number : NCT05555316

  • How Does Skin Tone Affect Quantitative Photoacoustic Imaging

    NCT Number : NCT05554523

  • Prevalence of Marginal Ulcer After PPPD and Preventive Effect of Proton Pump Inhibitor in Korea: A Prospective Multicenter Study

    NCT Number : NCT05551832

  • Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

    NCT Number : NCT05553327

  • Medical Thoracoscopy for Undiagnosed Transudative and Exudative Pleural Effusions

    NCT Number : NCT05553665

  • Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study

    NCT Number : NCT05555329

  • Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

    NCT Number : NCT05554211

  • Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

    NCT Number : NCT05554575

  • Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma

    NCT Number : NCT03713294

  • Allogenic CD19-targeting CAR-γδT Cell Therapy in r/r NHL

    NCT Number : NCT05554939

  • The Efficacy of Preventive Regenerative Peripheral Nerve Interface(RPNI) Reconstruction in Amputees

    NCT Number : NCT05554900

  • Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

    NCT Number : NCT05554913

  • Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Recurrent GBM

    NCT Number : NCT05370508

  • Contribution of Canine Detection in the Diagnostic Strategy of High-risk Prostate Cancer (Prostate-K9-Detect)

    NCT Number : NCT05558735

  • Micro-UltraSound In Cancer - Active Surveillance

    NCT Number : NCT05558241

  • An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

    NCT Number : NCT05558904

  • Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

    NCT Number : NCT05555732

  • Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

    NCT Number : NCT05557877

  • Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Epithelial Tumors Tumors (TETs)

    NCT Number : NCT05558644

  • The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients

    NCT Number : NCT05557825

  • Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic

    NCT Number : NCT05556772

  • Safety and Efficacy of Intravenous Cemiplimab Plus BNT116 Versus Cemiplimab Alone in Advanced Non-Small Cell Lung Cancer in Adult Participants With PD-L1 ≥ 50%

    NCT Number : NCT05557591

  • Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

    NCT Number : NCT05555706

  • A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

    NCT Number : NCT05557045

  • The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer (TORCH-E)

    NCT Number : NCT05555888

  • The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

    NCT Number : NCT05555901

  • Influence of Adiposity on IGF-1 and Fitness Response to Exercise in Cancer Survivors

    NCT Number : NCT05558384

  • Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

    NCT Number : NCT05558956

  • Needle-Based Confocal Laser Endomicroscopy With Fluorescein and Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules

    NCT Number : NCT05556525

  • GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence

    NCT Number : NCT05557578

  • The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism

    NCT Number : NCT05556499

  • Personalized Trial in ctDNA-level-relapse Glioblastoma

    NCT Number : NCT05539339

  • Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

    NCT Number : NCT04480814

  • Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer

    NCT Number : NCT05558436

  • A Safety Study of 212Pb-Pentixather Radioligand Therapy

    NCT Number : NCT05557708

  • F-Tryptophan PET/CT in Human Cancers

    NCT Number : NCT05556473

  • Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

    NCT Number : NCT05557474

  • Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

    NCT Number : NCT03694834

  • Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas

    NCT Number : NCT05557851

  • Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

    NCT Number : NCT03458676

  • Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

    NCT Number : NCT04490564

  • AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)

    NCT Number : NCT05556603

  • Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

    NCT Number : NCT05557604

  • A Study of Belantamab Mafodotin and Nirogacestat in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

    NCT Number : NCT05556798

  • Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer

    NCT Number : NCT04037254

  • Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer

    NCT Number : NCT05558722

  • Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

    NCT Number : NCT05561686

  • Exercise and Pain in CCS

    NCT Number : NCT05562193

  • Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy

    NCT Number : NCT05560659

  • Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

    NCT Number : NCT05561023

  • The Use of Photobiomodulation in the Management of Radiodermatitis in Breast Cancer Patients

    NCT Number : NCT05561803

  • Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

    NCT Number : NCT05560308

  • Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

    NCT Number : NCT05562297

  • Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

    NCT Number : NCT05559541

  • Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC

    NCT Number : NCT05560776

  • PY265 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

    NCT Number : NCT05560191

  • The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

    NCT Number : NCT05560035

  • SMART-ER: Symptom Monitoring With Patient-reported Outcomes

    NCT Number : NCT05560685

  • Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer

    NCT Number : NCT05561699

  • Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

    NCT Number : NCT05559879

  • MEthods for LOcalization of Different Types of Breast Lesions

    NCT Number : NCT05559411

  • Effects of Two Different Goals of Fluid Management in Patients Undergoing Supratentorial Tumour Resection

    NCT Number : NCT05561894

  • Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

    NCT Number : NCT05561387

  • The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population

    NCT Number : NCT05562440

  • An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

    NCT Number : NCT05559177

  • A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy

    NCT Number : NCT05559775

  • Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

    NCT Number : NCT05561842

  • A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations

    NCT Number : NCT05560334

  • BRaziLian outcomE for metAStatic breasT Cancer

    NCT Number : NCT05559528

  • RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

    NCT Number : NCT05557292

  • Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)

    NCT Number : NCT05559645

  • Identification of Breath Biomarkers in Esophageal Cancer

    NCT Number : NCT05557955

  • Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly and/or Frail Stage III Non-small-cell Lung Cancer

    NCT Number : NCT05557552

  • A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

    NCT Number : NCT05557565

  • Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

    NCT Number : NCT05559853

  • Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma

    NCT Number : NCT05536986

  • Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma

    NCT Number : NCT05532969

  • GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

    NCT Number : NCT05562518

  • Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on HPA

    NCT Number : NCT05557487

  • Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

    NCT Number : NCT05558007

  • A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor

    NCT Number : NCT05561036

  • Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

    NCT Number : NCT05555550

  • Effect and Mechanism of Remimazolam Benzenesulfonate on Enhanced Recovery After Surgery in Patients Undergoing Radical Gastrectomy for Gastric Cancer

    NCT Number : NCT05559151

  • Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

    NCT Number : NCT05482451

  • Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

    NCT Number : NCT05541042

  • Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment

    NCT Number : NCT05558397

  • PIPAC for the Treatment of Colorectal Peritoneal Metastases

    NCT Number : NCT03868228

  • Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

    NCT Number : NCT05556928

  • Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem

    NCT Number : NCT05556486

  • An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

    NCT Number : NCT05560009

  • Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

    NCT Number : NCT04729959

  • A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

    NCT Number : NCT05561491

  • A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

    NCT Number : NCT05556200

  • Gynaecology Exercise and Mindfulness Study

    NCT Number : NCT05561413

  • Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery

    NCT Number : NCT03532581

  • A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

    NCT Number : NCT05556616

  • Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

    NCT Number : NCT05556642

  • Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma

    NCT Number : NCT05518994

  • BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

    NCT Number : NCT05558982

  • Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

    NCT Number : NCT05556720

  • Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders

    NCT Number : NCT05562375

  • Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy

    NCT Number : NCT05561907

  • Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

    NCT Number : NCT05561374

  • Total Laparoscopic Distal Gastroectomy for Gastric Cancer

    NCT Number : NCT05556980

  • Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

    NCT Number : NCT03121677

  • A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

    NCT Number : NCT05560360

  • Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma

    NCT Number : NCT03282396

  • TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

    NCT Number : NCT05562024

  • Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

    NCT Number : NCT05555862

  • Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients

    NCT Number : NCT05561920

  • CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

    NCT Number : NCT05558124

  • Helicobacter Pylori Local Prevalence and Antibiotic Resistance

    NCT Number : NCT05561504

  • Effect of Ambroxol in Diabetic Peripheral Neuropathy

    NCT Number : NCT05558878

  • Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease)

    NCT Number : NCT05558592

  • Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

    NCT Number : NCT05556447

  • Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma

    NCT Number : NCT05558280

  • Evaluation of Radiotherapy After Complete Response to Sonic Hedgehog Pathway Inhibitors in Patients With Locally Advanced Basal Cell Carcinoma

    NCT Number : NCT05561634

  • Strategies to Connect Patients at Federally Qualified Health Clinics With Evidence Based Tobacco Cessation Treatment

    NCT Number : NCT03900767

  • Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients

    NCT Number : NCT05559242

  • Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

    NCT Number : NCT05561751

  • Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma

    NCT Number : NCT05561049

  • A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

    NCT Number : NCT05560399

  • STAY-STRONG Study of Exercise Training During Chemotherapy

    NCT Number : NCT05556239

  • A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom

    NCT Number : NCT05555979

  • Individual Dosimetric Monitoring of Workers During Interventional Radiology and Cardiology Procedures for Cardiologists and Radiologists in France

    NCT Number : NCT05561439

  • Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse

    NCT Number : NCT05559788

  • Efficacy of Trimetazidine in Diabetic Patients

    NCT Number : NCT05556005

  • Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery

    NCT Number : NCT04501042

  • Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma (HEARTS)

    NCT Number : NCT05561595

  • Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity

    NCT Number : NCT05556382

  • Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

    NCT Number : NCT05557695

  • Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL

    NCT Number : NCT05557110

  • Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation

    NCT Number : NCT05559827

  • Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital

    NCT Number : NCT05558943

  • A Real World Study of Regogfinib in HCC

    NCT Number : NCT05557656

  • Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)

    NCT Number : NCT05559905

  • The Supraspinal Control of Lower Urinary Tract Function in Patients With Orthotopic Sigmoid Neobladder.

    NCT Number : NCT05558111

  • Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

    NCT Number : NCT05559450

  • Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma

    NCT Number : NCT05557838

  • Bomedemstat in Patients With Polycythemia Vera

    NCT Number : NCT05558696

  • NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

    NCT Number : NCT05558319

  • Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

    NCT Number : NCT05556096

  • A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

    NCT Number : NCT05556512

  • Pulse Oxygen Saturation (SpO2) Directed Oxygen Therapy

    NCT Number : NCT02999932

  • FMT for Post-acute COVID-19 Syndrome

    NCT Number : NCT05556733

  • Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

    NCT Number : NCT05557903

  • Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

    NCT Number : NCT05557240

  • A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

    NCT Number : NCT04987489

  • A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

    NCT Number : NCT05559008

  • Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

    NCT Number : NCT05507450

  • Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients

    NCT Number : NCT05555680

OncoPower Clinical Trial Features

OncoPower Clinical Trial Features

provider-icon

Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you

provider-icon

Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria

provider-icon

Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants

provider-icon

Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.